Related Experiment Video
Updated: Oct 3, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
[Pharmacological study on functional significance of alpha 1-adrenoceptor subtypes in mammalian ventricular
1Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Abstract:
The present study was undertaken to determine alpha 1-adrenoceptor subtype involved in the inotropic, electrophysiological and phosphoinositide responses to myocardial alpha 1-adrenoceptor stimulation. Phenylephrine in the presence of the beta-adrenoceptor antagonist, propranolol, elicited a positive inotropic effect in a concentration-dependent manner in both rat and rabbit papillary muscles. In rat papillary muscle, the positive inotropic effect of phenylephrine was antagonized by the alpha 1A-selective antagonist, WB4101, but not affected by the alpha 1B-antagonist, chloroethylclonidine (CEC). On the other hand, the positive inotropic effect in rabbit papillary muscle was antagonized by both WB4101 and CEC. The inotropic response of rat papillary muscle to phenylephrine was composed of a negative inotropic phase and a positive inotropic phase, both of which were blocked only by WB4101. In both rat and rabbit papillary muscles, phenylephrine caused prolongation of action potential duration. WB4101, but not CEC, significantly suppressed the APD prolongation. Only in rat papillary muscle, phenylephrine exerted hyperpolarization of resting membrane potential, an effect which was also eliminated by WB4101. Furthermore, stimulation of phosphoinositide hydrolysis induced by phenylephrine (evaluated by [3H] inositol monophosphate accumulation) was inhibited by WB4101 in a concentration-dependent fashion, but the inhibitory effect on the response to phenylephrine was seen with CEC only at a higher concentration. From these results, it was concluded that both myocardial alpha 1A- and alpha 1B-adrenoceptor subtypes are able to mediate a positive inotropic effect, and that the alpha 1A-adrenoceptor-mediated positive inotropic effect is exclusively dependent on the prolongation of action potential duration, while the alpha 1B-adrenoceptor-mediated one appear to be due to a mechanism other than electrophysiological changes. In addition, based on the previous respects that the phosphatidyl-inositol hydrolytic products do not contribute to the alpha 1-adrenoceptor-mediated electrophysiological effects, the present data suggest that the coupling of alpha 1A-adrenoceptors to phosphatidylinositol hydrolysis may be independent of the positive inotropism.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: ɑ and β-Receptor Blockers

